Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Meilan M Rutter

6PUBLICATIONS
23CO-AUTHORS
PharmacogenomicsElectrical energy generation (incl. renewables, excl. photovoltaics)Clinical nutritionPhotonics, optoelectronics and optical communicationsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

Sort by Publication Date:
|Dec 23, 2025
Acute Adverse Events Following Intravenous Bisphosphonate Infusion Are Uncommon in Patients With Duchenne Muscular Dystrophy Previously Treated With Oral Bisphosphonates.

Nat Nasomyont, Pitchamol Vilaisaktipakorn, Halley Wasserman

|Oct 09, 2025
Epicardial Adipose Tissue in Duchenne Muscular Dystrophy Cardiomyopathy.

Eleanor Greiner, Kimberley G Miles, Zhiqian Gao

|Feb 20, 2025
A Parent Project Muscular Dystrophy-sponsored International Workshop Report on Endocrine and Bone Issues in Patients with Duchenne Muscular Dystrophy: An Ever-changing Landscape.

Leanne M Ward, David R Weber, Sze Choong Wong

|Nov 01, 2023
Successful Treatment of Hypoglycemia With Alpelisib in Pediatric Patients With <i>PIK3CA</i>-Related Overgrowth Spectrum.

Nat Nasomyont, Meilan M Rutter, Philippe F Backeljauw

|Sep 27, 2021
The Effect of Adiposity on Cardiovascular Function and Myocardial Fibrosis in Patients With Duchenne Muscular Dystrophy.

Sarah E Henson, Sean M Lang, Philip R Khoury

|Jul 18, 2020
Safety and efficacy of teriparatide treatment for severe osteoporosis in patients with Duchenne muscular dystrophy.

N Nasomyont, C Keefe, C Tian

Pageof 1

Frequent Collaborators

3 joint publications

Nat Nasomyont

1 joint publications

Sarah E Henson

1 joint publications

Philip R Khoury

1 joint publications

Elaine M Urbina

1 joint publications

Michael D Taylor

1 joint publications

Tarek Alsaied

1 joint publications

Philippe F Backeljauw

1 joint publications

Leanne M Ward

1 joint publications

David R Weber

1 joint publications

Paula R Clemens

Frequent Collaborators

3 joint publications

Nat Nasomyont

1 joint publications

Sarah E Henson

1 joint publications

Philip R Khoury

1 joint publications

Elaine M Urbina

Top Related Videos

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on : May 07, 2020

7.2K
A Guide to Examining Intramuscular Fat Formation and its Cellular Origin in Skeletal Muscle
09:19

A Guide to Examining Intramuscular Fat Formation and its Cellular Origin in Skeletal Muscle

Published on : May 26, 2022

4.7K
Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
09:18

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on : Jan 12, 2019

10.3K
See more related videos

Top Related Videos

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on : May 07, 2020

7.2K
A Guide to Examining Intramuscular Fat Formation and its Cellular Origin in Skeletal Muscle
09:19

A Guide to Examining Intramuscular Fat Formation and its Cellular Origin in Skeletal Muscle

Published on : May 26, 2022

4.7K
Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
09:18

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on : Jan 12, 2019

10.3K
See more related videos